Access Glofitamab Injection in Delhi India for DLBCL Care - Delhi

Tuesday, 11 March, 2025

Item details

City: Delhi
Offer type: Offer

Contacts

Contact name impomed healthcare

Item description

Patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) can benefit from Glofitamab Injection in India, a targeted therapy that helps activate the immune system to fight cancer cells. Impomed Healthcare facilitates access to this advanced treatment, ensuring reliable oncology solutions for those in need of effective care.
For more information visit: httpswww.impomedhealthcare.com